Market
Will the FDA approve gene-edited pig organ transplants for wider trials by end of 2025?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from the FDA
Story
Alabama Woman, 53, in 'Extraordinary' Health After Gene-Edited Pig Kidney Transplant
Dec 17, 2024, 02:28 PM
A 53-year-old Alabama woman is recovering well after receiving an experimental gene-edited pig kidney transplant last month at NYU Langone Health, freeing her from eight years of dialysis. This marks the latest effort to address organ shortages by using animal organs in human patients. Doctors report that she is in "extraordinary" health, making her the third living person to receive a pig kidney transplant successfully. The woman expressed gratitude, saying, "It's a blessing" and "I've been given a second chance at life." Previous attempts faced challenges, as four patients who received pig organs died within two months. The success of this procedure offers hope for improved outcomes and could pave the way for future advancements in organ transplantation.
View original story
Similar markets
No • 50%
Yes • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Fully approved • 25%
Approval denied • 25%
Still in experimental phase • 25%
Conditional approval • 25%
Other • 25%
United Kingdom • 25%
Canada • 25%
Australia • 25%
Lung transplant • 25%
Other organ transplant • 25%
Liver transplant • 25%
Heart transplant • 25%
Yes • 50%
No • 50%
Other • 25%
Australia • 25%
Canada • 25%
United Kingdom • 25%
0-5 • 25%
More than 15 • 25%
11-15 • 25%
6-10 • 25%